Page last updated: 2024-08-21
indazoles and at 7519
indazoles has been researched along with at 7519 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Berdini, V; Boulstridge, JA; Carr, MG; Cross, DM; Davis, DJ; Devine, LA; Early, TR; Feltell, RE; Lewis, EJ; McMenamin, RL; Navarro, EF; O'Brien, MA; O'Reilly, M; Reule, M; Saxty, G; Seavers, LC; Smith, DM; Squires, MS; Trewartha, G; Walker, MT; Woodhead, AJ; Woolford, AJ; Wyatt, PG | 1 |
| de Dios, A; Gelbert, LM; Lallena, MJ; Sánchez-Martínez, C | 1 |
Reviews
1 review(s) available for indazoles and at 7519
| Article | Year |
|---|---|
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.
Topics: Antineoplastic Agents; Cell Cycle; Cyclin-Dependent Kinase Inhibitor Proteins; Humans; Neoplasms | 2015 |
Other Studies
1 other study(ies) available for indazoles and at 7519
| Article | Year |
|---|---|
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Crystallography, X-Ray; Cyclin-Dependent Kinase 2; Drug Design; Enzyme Inhibitors; Humans; Mice; Piperidines; Pyrazoles; Structure-Activity Relationship | 2008 |